phrykt

Nautilus Biotechnology, Inc. (NAUT): who owns it and who trades it

As of Nov 12, 2026, NAUT insiders reported 2 open-market sales worth $11.8M and 1 purchase worth $65.2K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was AH Bio Fund II, L.P. (10% owner), with $11.8M. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Nautilus Biotechnology

From the latest filings

Overall: more buying than selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NAUT

93 funds and institutions reported NAUT shares worth $93.9M at the end of Q2 2026, about 40% of the company. The largest holder is Perceptive Advisors LLC with 9.2%.

Funds and institutions (13F) 40%Everyone else 60%

10 largest owners, by share of the company

Perceptive Advisors LLC9.2%
A16z Capital Management, L.L.C.7.1%
Cercano Management LLC5.6%
BlackRock, Inc.2.1%
Vanguard Capital Management LLC2.0%
Comprehensive Financial Management LLC1.7%
Citadel Advisors LLC1.5%
Geode Capital Management, LLC1.0%
Acadian Asset Management LLC0.8%
Clearstead Advisors, LLC0.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Perceptive Advisors LLC11.63M9.16%$21.8M-8%
A16z Capital Management, L.L.C.9.06M7.13%$16.9M-49%
Cercano Management LLC7.17M5.64%$13.4MNo change
BlackRock, Inc.2.69M2.11%$5M+1332%
Vanguard Capital Management LLC2.55M2.01%$4.8M+0%
Comprehensive Financial Management LLC2.21M1.74%$4.1MNo change
Citadel Advisors LLC1.90M1.49%$3.5MNew
Geode Capital Management, LLC1.27M1.00%$2.4M+110%
Acadian Asset Management LLC1.06M0.83%$2M+42%
Clearstead Advisors, LLC892,7870.70%$1.7M-62%
Susquehanna International Group, LLP890,9490.70%$1.7MNew
Sentinel Trust Co Lba750,0000.59%$1.4MNo change
Barclays PLC725,3210.57%$1.4M+889%
Renaissance Technologies LLC690,5140.54%$1.3M+160%
JPMorgan Chase & Co614,1770.48%$1.1MNew
State Street Corp559,5080.44%$1M+159%
Dimensional Fund Advisors LP475,8440.37%$889K+45%
Northern Trust Corp381,2340.30%$713K+256%
Hrt Financial LP361,0730.28%$675K+453%
Vanguard Fiduciary Trust Co353,0930.28%$660K+16%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NAUT insiders reported $65.2K of open-market purchases and $11.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$65.2K
1 trades, 1 people
Sales, 12 months
$11.8M
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jun 2, 2026
Filed Jun 4, 2026

Purchases and sales by month

$11.8M$11.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 2, 2026AH Bio Fund II, L.P. +510% ownerSale4.62M$2.35$10.8MForm 4
Jun 2, 2026AH Bio Fund II, L.P. +510% ownerSale384,026$2.35$902KForm 4
Mar 4, 2026Sujal M PatelCEOPurchase25,000$2.61$65.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
AH Bio Fund II, L.P.10% owner–$11.8MJun 2, 2026
Sujal M PatelCEO, President, and Secretary, Director, 10% owner$65.2K–Mar 4, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NAUT short interest

Low short interest. 4.6% of NAUT shares are sold short: about 1 share in 22. Over the last 12 reports the number of shares short went up 608%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 5.84M NAUT shares were sold short, 4.6% of the shares outstanding, up 3.9% from the report before. At the average daily volume of 11.59M shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

4.58%May 15Oct 305.21%

Days to cover

1.0May 15Oct 307.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265.84M4.58%+4%11.59M1.0
Oct 15, 20265.62M4.42%-3%12.60M1.0
Sep 30, 20265.77M4.54%+41%4.07M1.4
Sep 15, 20264.08M3.21%+7%1.26M3.2
Aug 31, 20263.81M3.00%+21%591,9046.4
Aug 14, 20263.15M2.48%+39%859,5623.7
Jul 31, 20262.27M1.79%+57%835,9182.7
Jul 15, 20261.45M1.14%+75%1.11M1.3
Jun 30, 2026829,5220.65%+53%1.33M1.0
Jun 15, 2026541,1390.43%-29%407,8371.3
May 29, 2026760,1570.60%-8%432,6651.8
May 15, 2026825,0260.65%+15%390,8652.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Nautilus Biotechnology company events

Nautilus Biotechnology filed 6 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 27, 2026.

  1. Oct 27, 2026ResultsReleased financial results. Filing
  2. Sep 11, 2026AgreementNautilus Biotechnology, Inc. entered into a Sales Agreement with TD Securities (USA), LLC to sell shares of the Company’s common stock, par value $0.0001 per share, having aggregate sales proceeds of up to $125 million, from time to time, through an “at the market” offering program under which TD… Filing
  3. Jul 28, 2026ResultsReleased financial results. Filing
  4. Jun 18, 2026VoteReported shareholder vote results. Filing
  5. Apr 28, 2026ResultsReleased financial results. Filing
  6. Feb 26, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Nautilus Biotechnology financials

Famous investors that hold NAUT

1 of the 50 well-known investors we track reported holding NAUT in their latest 13F filing. The largest position is Jim Simons's, worth $2.3M.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20261.62M$2.3M0.0%+134%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NAUT in the last 120 days.

FiledHolderFormStake
Nov 3, 2026Perceptive Advisors LLC13D/A3.9%
Nov 3, 2026Perceptive Advisors LLC13D/A3.9%

Questions about Nautilus Biotechnology, Inc. (NAUT) stock

Who owns the most NAUT stock?

The largest reported owner of Nautilus Biotechnology, Inc. (NAUT) is Perceptive Advisors LLC, with 9.2% of the company. In total, 93 funds and institutions reported holding NAUT at the end of Q2 2026, together about 40% of the shares. See the largest owners.

Are NAUT insiders buying or selling?

In the last 12 months, NAUT insiders reported 1 open-market purchase worth $65.2K and 2 sales worth $11.8M. The latest trade was on Jun 2, 2026. See every trade.

What is the short interest in NAUT?

As of Oct 30, 2026, 5.84M NAUT shares were sold short, 4.6% of the shares outstanding, up 3.9% from the report before. At the average daily volume of 11.59M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold NAUT?

1 of the 50 well-known investors we track reported NAUT in their latest 13F filing, including Jim Simons. The largest position is worth $2.3M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.